Detection of Oral and Throat Cancers Using OralViome Cancer Testing System
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorViome
About this trial
To evaluate the design, safety and efficacy of OralViome Cancer Testing system in the early detection of Oral and Throat Cancers using saliva metatranscriptomic analysis. This study will recruit only at existing clinical sites and will NOT use any additional clinical sites.
Eligibility criteria
Qualifiers
Signed Informed Consent obtained
18 years and older
At a high risk of developing oral or throat cancer based on clinician's discretion
Disqualifiers
Pregnancy
Use of fertility enhancing medications
Trial design
Treatments tested in this trial
- OralViome Cancer Testing System
Treatment groups
475 Participants
are divided into 4 treatment groupsLocations
1NYMC10595, New YorkNew York, United States
Sponsors and collaborators
Viome
Lead sponsor
New York Medical College
Collaborator
Source ClinicalTrials.gov